Diferencia entre revisiones de «Crotaline envenomation»

Sin resumen de edición
Línea 6: Línea 6:


==Clinical Features==
==Clinical Features==
#Fang marks, localized pain, progressive edema extending from bite site
*Fang marks, localized pain, progressive edema extending from bite site
##Edema near the airway or in muscle compartment may threaten life or limb
**Edema near the airway or in muscle compartment may threaten life or limb
#Nausea/vomiting, oral numbness/tingling, dizziness, muscle fasciculations
*Nausea/vomiting, oral numbness/tingling, dizziness, muscle fasciculations
#Ecchymoses may appear within minutes to hours
*Ecchymoses may appear within minutes to hours


==Diagnosis==
==Diagnosis==
#Must have a snakebite + evidence of tissue injury:
*Must have a snakebite + evidence of tissue injury:
##Local injury (swelling, pain, ecchymosis)
**Local injury (swelling, pain, ecchymosis)
##Hematologic abnormality (thrombocytopenia, elevated INR, hypofibrinogenemia)
**Hematologic abnormality (thrombocytopenia, elevated INR, hypofibrinogenemia)
##Systemic effects (oral swelling/paresthesias, metallic taste, hypotension, tachycardia)
**Systemic effects (oral swelling/paresthesias, metallic taste, hypotension, tachycardia)
#Absence of all of the above 8-12hr after bite indicates dry bite
*Absence of all of the above 8-12hr after bite indicates dry bite


==Work-Up==
==Work-Up==
#CBC
*CBC
#Coags
*Coags
#Fibrinogen
*Fibrinogen
#FDP
*FDP
#Chemistry
*Chemistry


==Differential Diagnosis==
==Differential Diagnosis==
Línea 29: Línea 29:


==Treatment==
==Treatment==
#Local Care
*Local Care
##Do not:
**Do not:
###Attempt to suck out the venom
***Attempt to suck out the venom
###Place the affected part in cold water
***Place the affected part in cold water
###Use a tourniquet or wrap
***Use a tourniquet or wrap
##Do:
**Do:
###Immobilize limb in a neutral position
***Immobilize limb in a neutral position
#Antivenom
*Antivenom
##Crotalidae Polyvalent Immune Fab (FabAV)
**Crotalidae Polyvalent Immune Fab (FabAV)
##Indications:
**Indications:
###Progression of swelling
***Progression of swelling
###Abnormal results on lab tests (plt < 100,000 or fibrinogen < 100)
***Abnormal results on lab tests (plt < 100,000 or fibrinogen < 100)
###Systemic manifestations (unstable vitals or AMS)
***Systemic manifestations (unstable vitals or AMS)
##Administration
**Administration
###The total volume but NOT the number of vials may be reduced in small children
***The total volume but NOT the number of vials may be reduced in small children
###Establish initial control of envenomation by giving 4-6 vials
***Establish initial control of envenomation by giving 4-6 vials
####Control achieved? (Cessation of progression of all components of envenomation, including labs checked 2 hours after infusion started)
****Control achieved? (Cessation of progression of all components of envenomation, including labs checked 2 hours after infusion started)
#####If yes infuse 2-vial doses at 6, 12, and 18hr after initial control achieved
*****If yes infuse 2-vial doses at 6, 12, and 18hr after initial control achieved
#####If no repeat infusion of 4-6 vials and then re-evaluate for control
*****If no repeat infusion of 4-6 vials and then re-evaluate for control
##Envenomation control measurement
**Envenomation control measurement
###Must observe for progression of envenomation during and after antivenom infusion
***Must observe for progression of envenomation during and after antivenom infusion
####Measure limb circumference at several site above and below bite
****Measure limb circumference at several site above and below bite
####Mark advancing border of edema q30min
****Mark advancing border of edema q30min
####Repeat labs q4hr or after each course of antivenom (whichever is more frequent)
****Repeat labs q4hr or after each course of antivenom (whichever is more frequent)
##Side Effects
**Side Effects
###Acute reactions occur in <10% pts
***Acute reactions occur in <10% pts
###If occurs stop infusion and give antihistamines / epi if needed
***If occurs stop infusion and give antihistamines / epi if needed
##Recurrent [[thrombocytopenia]] has been described up to 2 weeks after transfusion with FabAV
**Recurrent [[thrombocytopenia]] has been described up to 2 weeks after transfusion with FabAV
###Likely result of isolated renal clearance of FabAV and persistent presence of actual venom in serum
***Likely result of isolated renal clearance of FabAV and persistent presence of actual venom in serum
###Only described in patients with history of thrombocytopenia during hospital course
***Only described in patients with history of thrombocytopenia during hospital course
###warrants close monitoring of platelets by PMD or return visit after discharge
***warrants close monitoring of platelets by PMD or return visit after discharge
#Supportive care
*Supportive care
##IVF and pressors if needed for hypotension
**IVF and pressors if needed for hypotension
##Blood component replacement indicated if antivenom fails to stop active bleeding
**Blood component replacement indicated if antivenom fails to stop active bleeding
#[[Compartment syndrome]]
*[[Compartment syndrome]]
##If signs of compartment syndrome are present and pressure >30:
**If signs of compartment syndrome are present and pressure >30:
###Elevate limb
***Elevate limb
###Administer additional FabAV 4-6 vials IV over 60min
***Administer additional FabAV 4-6 vials IV over 60min
###If elevated compartment pressure persists another 60min consider fasciotomy
***If elevated compartment pressure persists another 60min consider fasciotomy


==Disposition==
==Disposition==
#Must observe all snakebite pts for at least 8hr before determining patient disposition
*Must observe all snakebite pts for at least 8hr before determining patient disposition
##Bites that initially appear innocuous and labs normal at presentation can be deceptive
**Bites that initially appear innocuous and labs normal at presentation can be deceptive
#Discharge if symptom-free after 8hr
*Discharge if symptom-free after 8hr
#Admit all pts receiving antivenom to the ICU
*Admit all pts receiving antivenom to the ICU
#Admit pts to the ward if have completed or do not require further antivenom therapy
*Admit pts to the ward if have completed or do not require further antivenom therapy


==See Also==
==See Also==

Revisión del 01:13 12 mar 2015

Background

  • Includes rattlesnakes and copperheads
  • Venom causes local tissue injury, hemolysis, coagulopathy, neuromuscular dysfunction
  • Up to 25% of bites are dry bites

Clinical Features

  • Fang marks, localized pain, progressive edema extending from bite site
    • Edema near the airway or in muscle compartment may threaten life or limb
  • Nausea/vomiting, oral numbness/tingling, dizziness, muscle fasciculations
  • Ecchymoses may appear within minutes to hours

Diagnosis

  • Must have a snakebite + evidence of tissue injury:
    • Local injury (swelling, pain, ecchymosis)
    • Hematologic abnormality (thrombocytopenia, elevated INR, hypofibrinogenemia)
    • Systemic effects (oral swelling/paresthesias, metallic taste, hypotension, tachycardia)
  • Absence of all of the above 8-12hr after bite indicates dry bite

Work-Up

  • CBC
  • Coags
  • Fibrinogen
  • FDP
  • Chemistry

Differential Diagnosis

Envenomations, bites and stings

Treatment

  • Local Care
    • Do not:
      • Attempt to suck out the venom
      • Place the affected part in cold water
      • Use a tourniquet or wrap
    • Do:
      • Immobilize limb in a neutral position
  • Antivenom
    • Crotalidae Polyvalent Immune Fab (FabAV)
    • Indications:
      • Progression of swelling
      • Abnormal results on lab tests (plt < 100,000 or fibrinogen < 100)
      • Systemic manifestations (unstable vitals or AMS)
    • Administration
      • The total volume but NOT the number of vials may be reduced in small children
      • Establish initial control of envenomation by giving 4-6 vials
        • Control achieved? (Cessation of progression of all components of envenomation, including labs checked 2 hours after infusion started)
          • If yes infuse 2-vial doses at 6, 12, and 18hr after initial control achieved
          • If no repeat infusion of 4-6 vials and then re-evaluate for control
    • Envenomation control measurement
      • Must observe for progression of envenomation during and after antivenom infusion
        • Measure limb circumference at several site above and below bite
        • Mark advancing border of edema q30min
        • Repeat labs q4hr or after each course of antivenom (whichever is more frequent)
    • Side Effects
      • Acute reactions occur in <10% pts
      • If occurs stop infusion and give antihistamines / epi if needed
    • Recurrent thrombocytopenia has been described up to 2 weeks after transfusion with FabAV
      • Likely result of isolated renal clearance of FabAV and persistent presence of actual venom in serum
      • Only described in patients with history of thrombocytopenia during hospital course
      • warrants close monitoring of platelets by PMD or return visit after discharge
  • Supportive care
    • IVF and pressors if needed for hypotension
    • Blood component replacement indicated if antivenom fails to stop active bleeding
  • Compartment syndrome
    • If signs of compartment syndrome are present and pressure >30:
      • Elevate limb
      • Administer additional FabAV 4-6 vials IV over 60min
      • If elevated compartment pressure persists another 60min consider fasciotomy

Disposition

  • Must observe all snakebite pts for at least 8hr before determining patient disposition
    • Bites that initially appear innocuous and labs normal at presentation can be deceptive
  • Discharge if symptom-free after 8hr
  • Admit all pts receiving antivenom to the ICU
  • Admit pts to the ward if have completed or do not require further antivenom therapy

See Also